Pharmaceuticals
Pfizer adds Celebrex warning label
Monday, 1 August 2005Pharmaceutical company Pfizer has changed the label of its Celebrex arthritis drug to add a prominent warning of possible cardiovascular risks, such as increased risk of heart attacks, in line with new warnings of other arthritis and pain drugs.
Pfizer said the package insert label of the drug - one of the company's biggest products, sales of which have recently declined sharply due to safety concerns - recommends that it be prescribed 'at the lowest effective dose for the shortest duration'.
Meanwhile, the company also said US regulators had approved a new use of the drug, for treatment of ankylosing spondylitis, a form of arthritis that affects the spine.
Advertisement
Advertisement
